Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Arcturus Therapeutics Holdings Inc. Common Stock

ARCT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ARCT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ARCT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ARCT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ARCT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ARCT holdings by institutional investors

Quarterly net insider trading by ARCT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $20,000 Jul 17, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 19, 2021 Issue: Health Issues Medicare/Medicaid
  • $90,000 Jan 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $100,000 Oct 25, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $80,000 Oct 19, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $30,000 Apr 17, 2020 Issue: Medical/Disease Research/Clinical Labs

Former government officials who have lobbied for ARCT

6 former government officials from 6 congressional offices at 2 lobbying firms have lobbied for ARCT, most recently Jan 20, 2021.

  • Orrin G. Hatch
    Derrick White Senate New Deputy Communications Director, Sen. Orrin Hatch (2000-2001) Formerly with Orrin G. Hatch · FORBES-TATE · Jan 20, 2021
  • Jean Schmidt
    Barry Bennett House Chief of Staff, Rep. Jean Schmidt, 2005-10; Communications Director, G8 Summit, State Dept., 2003-04 Formerly with Jean Schmidt · AVENUE STRATEGIES · Oct 25, 2020
  • Ron Kind
    Cynthia Brown House New Chief of Staff, Rep. Ron Kind (2003-2009); Legislative Director, Rep. Ron Kind (1999-2002) Formerly with Ron Kind · FORBES-TATE · Oct 19, 2020
  • Richard C. Shelby
    Wesley Welch Senate New Legislative Director, Sen. Richard Shelby (2005-2007); Legislative Assistant, Sen. Richard Shelby (2002-2005); Legislative Correspondent, Sen. Richard Shelby (2002) Formerly with Richard C. Shelby · FORBES-TATE · Aug 19, 2020
  • Susan W. Brooks
    Kristina Dunklin House New Legislative Director, Rep. Susan Brooks (2018-2019); Legislative Director, Rep. David Valadao (2015-2018); Legislative Assistant, Rep. David Valadao (2014-2015) Formerly with Susan W. Brooks · FORBES-TATE · Aug 19, 2020
  • Mike Crapo
    Barrett Thornhill Senate New Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003); Legislative Assistant, Rep. Charlie Norwood (2001-2002) Formerly with Mike Crapo · FORBES-TATE · Aug 19, 2020

ARCT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ARCT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ARCT Income Statement
ARCT Balance Sheet
ARCT Cash Flow
U.S. Patents

New ARCT patent grants

  • Patent Title: Ionizable cationic lipids for rna delivery Sep. 01, 2026
  • Patent Title: Ionizable cationic lipid for rna delivery May. 26, 2026
  • Patent Title: Ionizable cationic lipid for rna delivery Jan. 20, 2026
  • Patent Title: Synthesis and structure of high potency rna therapeutics Dec. 30, 2025
  • Patent Title: Ionizable cationic lipid for rna delivery Dec. 02, 2025
  • Patent Title: Compositions and methods for treating ornithine transcarbamylase deficiency Aug. 26, 2025
  • Patent Title: Compositions and methods for inducing immune responses Aug. 19, 2025
  • Patent Title: Compositions and methods for the treatment of ornithine transcarbamylase deficiency Jul. 08, 2025
  • Patent Title: Asialoglycoprotein receptor mediated delivery of therapeutically active conjugates May. 06, 2025
  • Patent Title: Method of synthesis of an ionizable cationic lipid Apr. 29, 2025
  • Patent Title: Method of making lipid-encapsulated rna nanoparticles Feb. 11, 2025
  • Patent Title: Coronavirus vaccine compositions and methods Feb. 11, 2025
  • Patent Title: Method of lyophilizing lipid nanoparticles Dec. 31, 2024
  • Patent Title: Lipid particles for nucleic acid delivery Sep. 10, 2024
  • Patent Title: Synthetic transfer rna with extended anticodon loop Sep. 03, 2024
  • Patent Title: Nucleic acids and methods of treatment for cystic fibrosis Aug. 27, 2024
  • Patent Title: Compositions and methods for treating phenylketonuria Mar. 26, 2024
  • Patent Title: Translatable molecules and synthesis thereof Mar. 26, 2024
  • Patent Title: Lipid nanoparticles encapsulation of large rna Mar. 26, 2024
  • Patent Title: Compositions and methods for inducing immune responses Sep. 19, 2023
  • Patent Title: Coronavirus vaccine compositions and methods Sep. 05, 2023
  • Patent Title: Method of making lipid-encapsulated rna nanoparticles Aug. 29, 2023
  • Patent Title: Molecules and agents for treating hepatitis b virus Jun. 27, 2023
  • Patent Title: Compositions and methods for treating ornithine transcarbamylase deficiency Jun. 27, 2023
  • Patent Title: Ionizable cationic lipid for rna delivery Oct. 04, 2022
  • Patent Title: Synthetic transfer rna with extended anticodon loop Sep. 06, 2022
  • Patent Title: Translatable molecules and synthesis thereof Aug. 09, 2022
  • Patent Title: Synthesis and structure of high potency rna therapeutics May. 25, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 20, 2021
  • Patent Title: Compositions and agents against hepatitis b virus and uses thereof Mar. 30, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 30, 2021
  • Patent Title: Messenger una molecules and uses thereof Oct. 27, 2020
  • Patent Title: Method of synthesis of an ionizable cationic lipid Sep. 22, 2020
  • Patent Title: Transthyretin allele selective una oligomers for gene silencing May. 29, 2018
  • Patent Title: Multiligand agent for drug delivery May. 08, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 24, 2018
  • Patent Title: Una single stranded oligomers for therapeutics Apr. 17, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 20, 2018
  • Patent Title: Formulations for treating amyloidosis Jan. 02, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Dec. 26, 2017
  • Patent Title: Aromatic ionizable cationic lipid Dec. 05, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Jun. 06, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 14, 2017
  • Patent Title: Lipid particles with asymmetric cationic lipids for rna delivery Feb. 28, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 14, 2017
  • Patent Title: Asymmetric ionizable cationic lipid for rna delivery Jun. 14, 2016
  • Patent Title: Una oligomer structures for therapeutic agents May. 17, 2016
  • Patent Title: Una duplex oligomers for therapeutics Apr. 05, 2016
  • Patent Title: Una oligomers targeting micro-rna for therapeutics Mar. 29, 2016
  • Patent Title: Una oligomers for therapeutics Jun. 09, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to ARCT from public contracts

ARCT News

Recent insights relating to ARCT

CNBC Recommendations

Recent picks made for ARCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ARCT

ARCT Analyst Ratings

ARCT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ARCT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ARCT stock a Buy, Sell, or Hold?

  • What is the price target for $ARCT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ARCT Top Shareholders
Shareholder
Shares Held
ARCT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ARCT stock?

  • Who owns the most shares of $ARCT stock?

  • What funds own $ARCT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ARCT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ARCT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ARCT

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

  • Address San Diego, CA
  • Market Cap 408.7 million
  • Employees 111
  • Industrial Classification Pharmaceutical Preparations

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Historical Stock Prices

Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) closed at $14.38 on September 22, 2026. Over the past year its adjusted close ranged from $5.53 to $23.16. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month+6.91%
  • 3 months+103.11%
  • Year to date+134.58%
  • 1 year-31.62%
  • 3 years-47.21%
  • 5 years-73.64%
  • Max-19.48%
See every congressional and insider trade on the ARCT price chart

Quiver Premium charts ARCT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 14.65 14.69 13.88 14.38 14.38 1,074,431
Sep 21, 2026 16.37 16.55 14.60 14.69 14.69 1,003,119
Sep 18, 2026 16.68 17.75 15.92 16.03 16.03 841,474
Sep 17, 2026 16.19 17.96 15.89 16.93 16.93 1,302,481
Sep 16, 2026 16.00 16.38 15.04 15.60 15.60 851,437
Sep 15, 2026 15.34 15.99 14.76 15.84 15.84 556,181
Sep 14, 2026 14.62 15.53 14.42 15.29 15.29 596,191
Sep 11, 2026 14.06 15.12 14.06 14.73 14.73 496,635
Sep 10, 2026 14.29 14.33 13.12 13.98 13.98 944,002
Sep 9, 2026 15.46 15.46 14.46 14.74 14.74 723,049
Sep 8, 2026 15.47 15.86 14.77 15.63 15.63 641,470
Sep 4, 2026 15.61 16.02 15.40 15.82 15.82 534,617
Sep 3, 2026 16.77 16.99 15.34 15.56 15.56 849,067
Sep 2, 2026 16.46 17.75 15.45 16.74 16.74 2,021,096
Sep 1, 2026 14.87 16.85 14.86 16.23 16.23 1,368,244
Aug 31, 2026 15.00 15.65 14.00 14.76 14.76 1,261,085
Aug 28, 2026 15.43 15.90 14.49 15.19 15.19 1,619,519
Aug 27, 2026 15.74 16.59 15.43 16.17 16.17 1,132,732
Aug 26, 2026 15.35 16.49 14.73 15.83 15.83 2,230,326
Aug 25, 2026 14.12 16.24 14.12 15.44 15.44 2,212,078
Aug 24, 2026 13.32 14.53 12.42 14.34 14.34 2,412,776
Aug 21, 2026 11.13 13.50 11.11 13.45 13.45 2,856,256
Aug 20, 2026 10.08 11.47 10.06 10.99 10.99 2,293,714
Aug 19, 2026 9.40 11.10 9.33 10.28 10.28 5,634,336
Aug 18, 2026 8.03 8.49 8.03 8.21 8.21 403,151
Aug 17, 2026 8.20 8.22 7.96 8.14 8.14 458,530
Aug 14, 2026 7.86 8.48 7.71 8.23 8.23 930,679
Aug 13, 2026 7.60 8.22 7.57 7.86 7.86 563,226
Aug 12, 2026 7.57 7.86 7.50 7.60 7.60 422,595
Aug 11, 2026 7.12 7.70 7.06 7.52 7.52 821,803
Aug 10, 2026 7.35 7.60 6.87 7.05 7.05 839,072
Aug 7, 2026 6.47 7.56 6.45 7.41 7.41 1,461,642
Aug 6, 2026 6.26 6.36 5.97 6.08 6.08 334,975
Aug 5, 2026 6.18 6.27 6.11 6.26 6.26 450,359
Aug 4, 2026 6.02 6.31 5.92 6.22 6.22 612,276
Aug 3, 2026 5.83 6.00 5.76 6.00 6.00 254,639
Jul 31, 2026 5.94 5.96 5.64 5.76 5.76 267,161
Jul 30, 2026 5.80 5.94 5.67 5.92 5.92 317,781
Jul 29, 2026 5.85 5.90 5.62 5.79 5.79 344,742
Jul 28, 2026 5.78 5.78 5.57 5.75 5.75 347,906
Jul 27, 2026 5.67 5.87 5.65 5.76 5.76 403,311
Jul 24, 2026 5.79 5.80 5.50 5.53 5.53 432,816
Jul 23, 2026 5.87 5.91 5.74 5.79 5.79 352,259
Jul 22, 2026 5.97 6.00 5.87 5.93 5.93 498,105
Jul 21, 2026 6.00 6.10 5.92 5.99 5.99 447,096
Jul 20, 2026 6.02 6.14 5.77 5.97 5.97 729,786
Jul 17, 2026 6.09 6.18 6.00 6.05 6.05 429,586
Jul 16, 2026 6.37 6.45 5.96 6.18 6.18 708,105
Jul 15, 2026 6.40 6.56 6.29 6.39 6.39 377,756
Jul 14, 2026 6.75 6.80 6.35 6.37 6.37 649,658
Jul 13, 2026 6.86 6.91 6.57 6.71 6.71 476,548
Jul 10, 2026 7.22 7.22 6.77 6.97 6.97 406,783
Jul 9, 2026 7.27 7.55 6.79 7.16 7.16 890,188
Jul 8, 2026 7.46 7.60 7.06 7.30 7.30 526,884
Jul 7, 2026 7.34 7.67 7.30 7.60 7.60 408,427
Jul 6, 2026 7.24 7.66 7.13 7.35 7.35 549,562
Jul 2, 2026 7.32 8.28 7.26 7.28 7.28 1,905,527
Jul 1, 2026 6.74 7.08 6.74 6.89 6.89 418,529
Jun 30, 2026 6.86 6.99 6.69 6.72 6.72 398,475
Jun 29, 2026 6.88 7.01 6.68 6.82 6.82 394,709
Jun 26, 2026 7.04 7.17 6.82 6.88 6.88 1,055,702
Jun 25, 2026 7.01 7.20 6.80 6.82 6.82 336,839
Jun 24, 2026 7.08 7.38 6.97 7.01 7.01 523,922
Jun 23, 2026 7.15 7.42 7.05 7.08 7.08 339,741
Jun 22, 2026 7.59 7.87 7.19 7.23 7.23 347,353
Jun 18, 2026 7.56 7.79 7.35 7.53 7.53 466,268
Jun 17, 2026 7.17 7.57 7.16 7.36 7.36 379,030
Jun 16, 2026 7.27 7.38 7.00 7.14 7.14 200,414
Jun 15, 2026 7.14 7.39 7.14 7.33 7.33 261,918
Jun 12, 2026 6.97 7.11 6.82 6.97 6.97 286,293
Jun 11, 2026 6.89 7.04 6.71 6.97 6.97 316,389
Jun 10, 2026 7.14 7.30 6.80 6.89 6.89 316,194
Jun 9, 2026 7.28 7.43 6.92 7.16 7.16 242,351
Jun 8, 2026 7.38 7.41 7.08 7.12 7.12 334,562
Jun 5, 2026 7.96 8.02 7.23 7.30 7.30 412,893
Jun 4, 2026 7.58 8.19 7.58 8.04 8.04 704,299
Jun 3, 2026 7.58 7.64 7.39 7.60 7.60 469,239
Jun 2, 2026 7.83 7.86 7.49 7.65 7.65 466,475
Jun 1, 2026 7.90 7.91 7.55 7.77 7.77 394,677
May 29, 2026 7.89 8.05 7.79 7.92 7.92 411,234
May 28, 2026 7.63 8.02 7.61 7.92 7.92 298,280
May 27, 2026 7.25 7.95 7.25 7.66 7.66 455,478
May 26, 2026 7.13 7.42 7.09 7.21 7.21 334,555
May 22, 2026 7.11 7.27 7.01 7.03 7.03 266,452
May 21, 2026 6.82 7.15 6.71 7.02 7.02 341,447
May 20, 2026 6.70 6.95 6.70 6.82 6.82 428,389
May 19, 2026 6.97 6.97 6.67 6.69 6.69 545,267
May 18, 2026 7.43 7.50 6.95 7.03 7.03 646,310
May 15, 2026 7.71 7.78 7.40 7.47 7.47 548,284
May 14, 2026 8.39 8.53 7.80 7.83 7.83 522,428
May 13, 2026 8.34 8.47 8.15 8.26 8.26 386,182
May 12, 2026 8.58 8.96 8.18 8.25 8.25 689,714
May 11, 2026 9.19 9.57 8.61 8.63 8.63 498,848
May 8, 2026 8.22 9.58 7.86 9.22 9.22 933,793
May 7, 2026 9.11 9.19 8.66 8.90 8.90 491,384
May 6, 2026 8.47 9.17 8.47 9.13 9.13 416,096
May 5, 2026 8.68 8.83 8.22 8.41 8.41 443,610
May 4, 2026 8.63 8.88 8.55 8.57 8.57 255,922
May 1, 2026 8.56 8.76 8.40 8.63 8.63 311,692
Apr 30, 2026 8.32 8.80 8.26 8.62 8.62 260,296
Apr 29, 2026 8.75 8.81 8.33 8.40 8.40 252,583
Apr 28, 2026 8.30 8.90 8.28 8.87 8.87 429,168
Apr 27, 2026 8.58 8.80 8.28 8.30 8.30 254,351
Apr 24, 2026 8.52 8.76 8.32 8.59 8.59 266,330
Apr 23, 2026 8.67 8.86 8.40 8.47 8.47 256,451
Apr 22, 2026 8.98 9.06 8.56 8.62 8.62 325,694
Apr 21, 2026 8.89 9.06 8.73 8.82 8.82 302,930
Apr 20, 2026 8.75 8.96 8.55 8.90 8.90 288,521
Apr 17, 2026 9.00 9.19 8.83 8.85 8.85 499,781
Apr 16, 2026 8.71 8.87 8.44 8.84 8.84 408,517
Apr 15, 2026 8.75 8.93 8.61 8.62 8.62 390,670
Apr 14, 2026 8.64 8.78 8.56 8.68 8.68 339,813
Apr 13, 2026 8.20 8.58 8.10 8.46 8.46 255,417
Apr 10, 2026 8.30 8.43 8.19 8.36 8.36 374,773
Apr 9, 2026 8.46 8.46 8.20 8.22 8.22 333,791
Apr 8, 2026 8.96 9.08 8.27 8.50 8.50 637,021
Apr 7, 2026 8.13 8.52 8.09 8.51 8.51 405,539
Apr 6, 2026 8.07 8.56 8.06 8.22 8.22 385,452
Apr 2, 2026 7.52 8.27 7.52 8.03 8.03 506,121
Apr 1, 2026 7.90 8.18 7.82 7.85 7.85 820,657
Mar 31, 2026 7.29 7.78 7.10 7.72 7.72 914,807
Mar 30, 2026 7.00 7.16 6.77 6.90 6.90 661,099
Mar 27, 2026 7.08 7.21 6.58 6.76 6.76 636,178
Mar 26, 2026 7.00 7.45 6.98 7.08 7.08 407,879
Mar 25, 2026 6.81 7.17 6.80 7.06 7.06 494,587
Mar 24, 2026 6.74 6.77 6.60 6.65 6.65 361,218
Mar 23, 2026 6.76 6.96 6.64 6.87 6.87 584,956
Mar 20, 2026 6.75 6.84 6.54 6.63 6.63 752,061
Mar 19, 2026 6.42 6.83 6.40 6.72 6.72 394,958
Mar 18, 2026 6.56 6.70 6.39 6.55 6.55 554,877
Mar 17, 2026 6.62 6.68 6.36 6.39 6.39 690,961
Mar 16, 2026 6.83 6.83 6.50 6.63 6.63 654,591
Mar 13, 2026 7.05 7.25 6.64 6.68 6.68 453,649
Mar 12, 2026 7.31 7.32 6.97 7.00 7.00 448,677
Mar 11, 2026 7.62 7.73 7.32 7.46 7.46 568,566
Mar 10, 2026 7.52 7.82 7.38 7.62 7.62 484,373
Mar 9, 2026 6.89 7.40 6.80 7.36 7.36 491,593
Mar 6, 2026 7.01 7.21 6.95 7.11 7.11 486,145
Mar 5, 2026 7.40 7.54 7.12 7.25 7.25 565,317
Mar 4, 2026 7.51 7.70 6.79 7.58 7.58 883,929
Mar 3, 2026 7.99 8.00 7.29 7.91 7.91 727,273
Mar 2, 2026 7.99 8.43 7.96 8.35 8.35 445,981
Feb 27, 2026 8.15 8.48 8.06 8.23 8.23 318,943
Feb 26, 2026 8.30 8.40 8.05 8.32 8.32 310,815
Feb 25, 2026 8.26 8.65 8.26 8.30 8.30 384,869
Feb 24, 2026 7.70 8.40 7.67 8.18 8.18 440,342
Feb 23, 2026 7.67 8.23 7.64 7.67 7.67 500,956
Feb 20, 2026 7.79 7.93 7.54 7.67 7.67 409,691
Feb 19, 2026 7.50 8.00 7.45 7.97 7.97 448,583
Feb 18, 2026 7.39 7.69 7.31 7.51 7.51 383,028
Feb 17, 2026 7.17 7.47 7.17 7.40 7.40 296,398
Feb 13, 2026 7.16 7.45 7.05 7.21 7.21 318,645
Feb 12, 2026 7.42 7.68 7.11 7.17 7.17 433,834
Feb 11, 2026 7.50 7.60 7.17 7.40 7.40 298,855
Feb 10, 2026 7.54 7.94 7.50 7.57 7.57 535,950
Feb 9, 2026 7.56 7.56 7.20 7.53 7.53 262,025
Feb 6, 2026 7.24 7.63 7.01 7.57 7.57 570,361
Feb 5, 2026 7.24 7.49 7.00 7.02 7.02 494,579
Feb 4, 2026 7.33 7.53 7.15 7.33 7.33 496,125
Feb 3, 2026 7.37 7.95 7.26 7.32 7.32 602,744
Feb 2, 2026 7.44 7.59 7.27 7.37 7.37 437,612
Jan 30, 2026 7.47 7.60 7.18 7.47 7.47 469,079
Jan 29, 2026 7.37 7.70 7.24 7.57 7.57 554,129
Jan 28, 2026 7.50 7.62 7.28 7.37 7.37 314,822
Jan 27, 2026 7.40 7.59 7.33 7.46 7.46 292,086
Jan 26, 2026 7.50 7.50 7.27 7.36 7.36 296,206
Jan 23, 2026 7.70 7.77 7.41 7.53 7.53 423,289
Jan 22, 2026 7.36 7.89 7.32 7.59 7.59 642,799
Jan 21, 2026 7.05 7.35 7.00 7.27 7.27 357,823
Jan 20, 2026 7.01 7.28 6.95 7.10 7.10 498,381
Jan 16, 2026 7.60 7.74 7.29 7.29 7.29 419,684
Jan 15, 2026 7.78 7.82 7.45 7.61 7.61 421,922
Jan 14, 2026 7.56 7.79 7.42 7.73 7.73 627,544
Jan 13, 2026 7.61 7.93 7.48 7.57 7.57 927,378
Jan 12, 2026 7.08 7.57 6.91 7.53 7.53 1,061,293
Jan 9, 2026 6.85 6.97 6.70 6.78 6.78 352,166
Jan 8, 2026 6.74 6.87 6.63 6.77 6.77 444,963
Jan 7, 2026 6.65 6.99 6.65 6.84 6.84 525,532
Jan 6, 2026 6.26 6.69 6.26 6.61 6.61 476,080
Jan 5, 2026 6.34 6.40 6.13 6.37 6.37 494,923
Jan 2, 2026 6.19 6.33 6.11 6.25 6.25 424,393
Dec 31, 2025 6.10 6.17 6.01 6.13 6.13 635,116
Dec 30, 2025 6.14 6.28 6.09 6.19 6.19 458,047
Dec 29, 2025 6.13 6.29 6.07 6.16 6.16 592,590
Dec 26, 2025 6.47 6.47 6.15 6.16 6.16 441,903
Dec 24, 2025 6.45 6.56 6.40 6.50 6.50 239,562
Dec 23, 2025 6.49 6.61 6.34 6.43 6.43 477,235
Dec 22, 2025 6.54 6.75 6.47 6.59 6.59 590,208
Dec 19, 2025 6.44 6.62 6.40 6.53 6.53 1,718,676
Dec 18, 2025 6.55 6.79 6.38 6.43 6.43 521,139
Dec 17, 2025 7.09 7.21 6.49 6.52 6.52 688,955
Dec 16, 2025 7.16 7.36 6.92 7.13 7.13 520,808
Dec 15, 2025 7.37 7.54 7.12 7.25 7.25 555,394
Dec 12, 2025 7.52 7.62 7.33 7.46 7.46 683,737
Dec 11, 2025 7.65 7.76 7.46 7.52 7.52 522,941
Dec 10, 2025 7.21 7.68 7.04 7.67 7.67 1,050,802
Dec 9, 2025 7.39 7.46 7.17 7.20 7.20 668,793
Dec 8, 2025 7.17 7.74 7.00 7.45 7.45 875,670
Dec 5, 2025 6.85 7.19 6.84 7.13 7.13 1,362,510
Dec 4, 2025 6.54 6.85 6.47 6.83 6.83 666,379
Dec 3, 2025 6.30 6.61 6.23 6.59 6.59 808,375
Dec 2, 2025 6.51 6.51 6.07 6.25 6.25 751,857
Dec 1, 2025 6.62 6.75 6.35 6.49 6.49 745,462
Nov 28, 2025 6.83 6.90 6.75 6.79 6.79 302,007
Nov 26, 2025 6.83 6.89 6.60 6.80 6.80 715,544
Nov 25, 2025 6.43 6.84 6.32 6.80 6.80 1,257,655
Nov 24, 2025 6.28 6.38 6.07 6.33 6.33 778,237
Nov 21, 2025 5.93 6.49 5.90 6.26 6.26 1,443,069
Nov 20, 2025 6.23 6.38 5.85 5.90 5.90 1,013,006
Nov 19, 2025 6.66 6.69 6.02 6.04 6.04 1,036,111
Nov 18, 2025 6.71 6.82 6.57 6.62 6.62 1,208,210
Nov 17, 2025 7.26 7.32 6.72 6.76 6.76 861,719
Nov 14, 2025 7.44 7.65 7.26 7.27 7.27 1,126,878
Nov 13, 2025 8.03 8.22 7.76 7.77 7.77 864,831
Nov 12, 2025 8.59 8.65 8.09 8.13 8.13 1,173,050
Nov 11, 2025 8.85 9.29 8.49 8.67 8.67 839,985
Nov 10, 2025 8.92 9.02 8.55 8.78 8.78 753,685
Nov 7, 2025 8.14 8.78 7.93 8.72 8.72 1,177,185
Nov 6, 2025 8.61 8.62 8.23 8.29 8.29 1,053,692
Nov 5, 2025 8.98 8.99 8.61 8.64 8.64 1,251,784
Nov 4, 2025 9.17 9.40 8.84 8.93 8.93 855,475
Nov 3, 2025 10.12 10.12 9.23 9.30 9.30 1,035,552
Oct 31, 2025 9.81 10.04 9.65 9.97 9.97 929,551
Oct 30, 2025 9.48 9.98 9.41 9.63 9.63 1,050,773
Oct 29, 2025 9.93 9.94 9.36 9.44 9.44 1,267,100
Oct 28, 2025 10.50 10.50 9.71 9.88 9.88 2,095,058
Oct 27, 2025 11.38 11.47 10.50 10.59 10.59 2,939,611
Oct 24, 2025 12.00 12.07 10.72 11.22 11.22 3,862,057
Oct 23, 2025 11.42 12.10 10.88 12.00 12.00 4,160,152
Oct 22, 2025 9.90 11.69 9.19 11.54 11.54 15,239,411
Oct 21, 2025 21.45 24.17 20.80 23.16 23.16 2,265,657
Oct 20, 2025 21.39 22.60 20.91 21.51 21.51 1,194,555
Oct 17, 2025 21.42 22.13 20.40 20.66 20.66 647,327
Oct 16, 2025 21.83 22.30 20.93 21.73 21.73 628,676
Oct 15, 2025 21.25 22.22 20.45 21.57 21.57 1,152,976
Oct 14, 2025 18.98 22.40 18.73 21.25 21.25 1,103,743
Oct 13, 2025 19.15 19.80 18.79 19.39 19.39 599,730
Oct 10, 2025 19.97 20.25 18.37 18.95 18.95 954,923
Oct 9, 2025 20.96 21.19 19.62 19.68 19.68 1,046,240
Oct 8, 2025 20.50 21.25 19.46 21.20 21.20 984,007
Oct 7, 2025 21.14 21.59 20.20 20.47 20.47 755,334
Oct 6, 2025 22.56 22.92 20.72 21.01 21.01 1,476,248
Oct 3, 2025 21.97 23.59 20.08 22.56 22.56 1,684,027
Oct 2, 2025 20.70 21.94 20.46 21.88 21.88 680,585
Oct 1, 2025 19.27 21.27 18.80 20.48 20.48 1,136,865
Sep 30, 2025 18.88 19.05 17.92 18.43 18.43 629,559
Sep 29, 2025 22.13 22.13 18.74 18.78 18.78 1,434,654
Sep 26, 2025 20.55 22.40 20.51 22.17 22.17 915,677
Sep 25, 2025 19.80 20.50 19.56 20.31 20.31 413,605
Sep 24, 2025 20.82 21.32 20.40 20.45 20.45 422,162
Sep 23, 2025 21.10 21.26 20.18 20.26 20.26 773,394
Sep 22, 2025 20.50 21.66 20.18 21.03 21.03 683,204

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Arcturus Therapeutics Holdings Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ARCT, per a recent SEC DEF 14A filing. We estimate that the median employee at Arcturus Therapeutics Holdings Inc. is paid $231,000.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation